Functional groups on polystyrene model nanoparticles: influence on protein adsorption.
暂无分享,去创建一个
Rainer H Müller | R. Müller | B. Paulke | Andrea Gessner | Antje Lieske | A. Gessner | Bernd-R Paulke | A. Lieske
[1] Interactions of functionalized polystyrene derivatives with the complement system in human serum. , 1991, Journal of biomaterials science. Polymer edition.
[2] R. Schwendener,et al. The effects of charge and size on the interaction of unilamellar liposomes with macrophages. , 1984, Biochimica et biophysica acta.
[3] R. Müller,et al. Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vitro interaction with plasma proteins. , 1996, Clinical nutrition.
[4] R. Müller,et al. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. , 2001, International journal of pharmaceutics.
[5] R. Müller,et al. Plasma protein adsorption patterns on emulsions for parenteral administration: Establishment of a protocol for two‐dimensional polyacrylamide electrophoresis , 1998, Electrophoresis.
[6] M. Kazatchkine,et al. Anticomplementary activity of dextran derivatives. , 1985, Biomaterials.
[7] C. J. Oss,et al. Phagocytosis as a Surface Phenomenon , 1978 .
[8] R. Müller,et al. Evaluation of desorption of proteins adsorbed to hydrophilic surfaces by two‐dimensional electrophoresis , 2001, Proteomics.
[9] M. Kazatchkine,et al. Regulation of the human alternative complement pathway: formation of a ternary complex between factor h, surface‐bound c3b and chemical groups on nonactivating surfaces , 1989, European journal of immunology.
[10] S. Krilis,et al. Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Wurm. beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. , 1984, The International journal of biochemistry.
[12] D. Hochstrasser,et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .
[13] M. Lück,et al. Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis. , 1999, Biomaterials.
[14] R. Müller,et al. Identification of plasma proteins facilitated by enrichment on particulate surfaces: Analysis by two‐dimensional electrophoresis and N‐terminal microsequencing , 1997, Electrophoresis.
[15] D. Hochstrasser,et al. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.
[16] R. Müller,et al. Analysis of plasma protein adsorption onto polystyrene particles by two‐dimensional electrophoresis: Comparison of sample application and isoelectric focusing techniques , 2000, Electrophoresis.
[17] H. Brewer,et al. Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). , 1980, Biochemical and biophysical research communications.
[18] H M Patel,et al. Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.
[19] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] M. Kazatchkine,et al. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. , 1988, Molecular immunology.
[21] R. Müller,et al. Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. , 2002, Biochimica et biophysica acta.
[22] K. Tauer,et al. Emulsion polymerization in the presence of polymerizable emulsifiers and surface active initiators , 1990 .
[23] B. Paulke,et al. Electrophoretic 3D-Mobility Profiles of Latex Particles with Different Surface Groups , 1995 .
[24] W. Norde,et al. Why proteins prefer interfaces. , 1991, Journal of biomaterials science. Polymer edition.
[25] P. Artursson,et al. Biopharmaceutics of Microparticulate Drug Carriers , 1987, Annals of the New York Academy of Sciences.
[26] H. Ayhan,et al. Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. , 1995, Journal of biomaterials science. Polymer edition.
[27] C. Haynes,et al. Globular proteins at solid/liquid interfaces , 1994 .
[28] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[29] A. L. Adams,et al. Adsorption of proteins out of plasma and solutions in narrow spaces , 1986 .
[30] M. Lück,et al. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.
[31] M. Kazatchkine,et al. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. , 1993, Biomaterials.
[32] M. Kamboh,et al. Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding , 1998, Lupus.